Mochida And Ayumi Launch Unique Humira Biosimilar Formulation In Japan
Launch And NHI Listing Follows Approval In March This Year
A new formulation of biosimilar Humira is now available in Japan, alongside three other presentations that join biosimilar products launched by partners Viatris and Fujifilm Kyowa Kirin Biologics at the start of this year.
